Skip Navigation

Pranita D Tamma, M.D., M.P.H.

Pranita D Tamma, M.D., M.P.H.

Headshot of Pranita D Tamma
  • Director, Pediatric Antimicrobial Stewardship Program
  • Associate Professor of Pediatrics


Pediatric Infectious Diseases

Research Interests

Diagnosing and treating multidrug-resistant infections; improving antibiotic use among children and adults more


The Johns Hopkins Hospital (Main Entrance)

1800 Orleans St.
Sheikh Zayed Tower
Baltimore, MD 21287 map
Phone: 410-614-1492

Johns Hopkins Harriet Lane Clinic

200 N. Wolfe Street
Rubenstein Child Health Building, Suite 3149
Baltimore, MD 21287 map
Phone: 410-614-3917


Pranita Tamma, M.D., M.H.S. is an Associate Professor of Pediatrics in the Division of Infectious Diseases and Director of the Pediatric Antimicrobial Stewardship Program at The Johns Hopkins University School of Medicine. As Director of Antimicrobial Stewardship, she assists clinicians with optimizing the selection of antibiotics to improve patient outcomes while minimizing antibiotic-associated harm. She is the past and present recipient of federal research funding from the National Institutes of Health, Food and Drug Administration, Centers for Disease Control and Prevention, and Agency for Healthcare Research and Quality. Her research focuses on improving our understanding of the mechanisms of gram-negative bacterial resistance, improving available phenotypic and molecular diagnostics to identify gram-negative resistant pathogens, and optimizing therapeutic choices for infections caused by multidrug-resistant gram-negative organisms, including novel therapies like bacteriophages.

Dr. Tamma is an editor at Antimicrobial Agents and Chemotherapy and is a member of the Antibacterial Resistance Leadership Group Gram-Negative Subcommittee. more


  • Director, Pediatric Antimicrobial Stewardship Program
  • Associate Professor of Pediatrics

Departments / Divisions



  • MD; SUNY Downstate Medical Center (2004)


  • Pediatrics; Johns Hopkins University School of Medicine (2007)


  • Pediatric Infectious Diseases; Johns Hopkins University School of Medicine (2011)

Board Certifications

  • American Board of Pediatrics (Pediatric Infectious Diseases) (2011)

Research & Publications

Selected Publications

View all on PubMed

Goodman K, Lessler J, Cosgrove SE, Harris AD, Lautenbach E, Han JH, Milstone AM, Masey C, & Tamma PD. A clinical decision tree to predict whether a bacteremic patient is infected with an ESBL-producing organism. Clin Infect Dis. 2016 Jun 28. pii: ciw425. [Epub ahead of print]

Suwantarat N, Logan LK, Carroll KC, Bonomo RA, Simner PJ, Rudin S, Milstone AM, Tekle T, Ross MT, Tamma PD. The prevalence and molecular epidemiology of multidrug-resistant Enterobacteriaceae colonization in a pediatric intensive care unit. Infect Control Hosp Epidemiol. 2016;37(5):535-43.

Tamma PD, Han JH, Rock C, Harris AD, Lautenbach E, Hsu AJ, Avdic E, Cosgrove SE. Carbapenem therapy is associated with improved survival compared to piperacillin-tazobactam in patients with ESBL bacteremia. Clin Infect Dis. 2015; 60:1319-25

Tamma PD, Goodman KE, Harris AD, Tekle T, Robert A, Taiwo A, & Simner PJ. Comparing the Outcomes of Patients with Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia. Clinical Infectious Diseases 2017;64(3):257-264. 

Tamma PD, Opene BNA, Gluck A, Chambers K, Carroll KC, & Simner PJ. A Comparison of Eleven Phenotypic Assays for the Accurate Detection of Carbapenemase-Producing Enterobacteriaceae. Journal of Clinical Microbiology; 2017; 64(3):257-264

Activities & Honors


  • Society for Healthcare Epidemiology of America, 2009
  • The Pediatric Infectious Diseases Society, 2008
  • Infectious Diseases Society of America, 2008
Is this you? Edit Profile
back to top button